• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新思考药物研发项目中的领导力。

Rethinking leadership in drug discovery projects.

机构信息

ETH Zurich, Department of Management, Technology and Economics, Zurich, Switzerland.

出版信息

Drug Discov Today. 2012 Dec;17(23-24):1258-62. doi: 10.1016/j.drudis.2012.06.005. Epub 2012 Jun 15.

DOI:10.1016/j.drudis.2012.06.005
PMID:22706018
Abstract

Great efforts have been dedicated to rebuilding the engine of pharmaceutical R&D. However, one potential area of improvement has received limited attention in the literature and in practice: namely, leadership. In this article, we enrich the traditional views of leadership, which consider leadership a responsibility of a few centrally placed authorities, with the concept of distributed leadership. Distributed leadership reflects a group-based capability driven by everyday activities and the key scientific questions at hand. We identify three leadership challenges faced by R&D teams that could be addressed by implementing distributed leadership. Furthermore, we provide some suggestions as to how to foster distributed leadership in drug discovery projects.

摘要

人们为重建药物研发的引擎付出了巨大努力。然而,在文献和实践中,一个有潜力的改进领域却受到了有限的关注:即领导力。在本文中,我们用分布式领导力的概念丰富了传统的领导力观点,这种观点将领导力视为少数核心权威的责任。分布式领导力反映了一种基于日常活动和当前关键科学问题的群体能力。我们确定了研发团队面临的三个领导力挑战,这些挑战可以通过实施分布式领导力来解决。此外,我们还就如何在药物发现项目中培养分布式领导力提出了一些建议。

相似文献

1
Rethinking leadership in drug discovery projects.重新思考药物研发项目中的领导力。
Drug Discov Today. 2012 Dec;17(23-24):1258-62. doi: 10.1016/j.drudis.2012.06.005. Epub 2012 Jun 15.
2
What is the most important approach in current drug discovery: doing the right things or doing things right?在当前的药物发现中,最重要的方法是什么:做正确的事还是把事情做对?
Drug Discov Today. 2012 Nov;17(21-22):1166-9. doi: 10.1016/j.drudis.2012.04.009. Epub 2012 Apr 27.
3
Deploying continuous improvement across the drug discovery value chain.在药物发现价值链中部署持续改进。
Drug Discov Today. 2011 Jun;16(11-12):467-71. doi: 10.1016/j.drudis.2011.03.007. Epub 2011 Apr 3.
4
The innovative medicines initiative: a European response to the innovation challenge.创新药物倡议:欧洲对创新挑战的回应。
Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8.
5
Can open-source drug R&D repower pharmaceutical innovation?开源药物研发能否重振药物创新?
Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26.
6
Rebuilding the R&D engine in big pharma.重塑大型制药公司的研发引擎。
Harv Bus Rev. 2008 May;86(5):68-70, 72-6, 128.
7
Six Sigma: not for the faint of heart.六西格玛:并非胆小者所能驾驭。
Radiol Manage. 2003 Mar-Apr;25(2):40-53.
8
The cost of harm and savings through safety: using simulated patients for leadership decision support.伤害成本与安全节约:使用模拟患者为领导力决策提供支持。
J Patient Saf. 2012 Sep;8(3):89-96. doi: 10.1097/PTS.0b013e318258cb25.
9
The hidden challenges in role transitions and how leadership coaching can help new leaders find solid ground.角色转变中的潜在挑战以及领导力辅导如何帮助新领导者站稳脚跟。
Holist Nurs Pract. 2011 Jul-Aug;25(4):211-4. doi: 10.1097/HNP.0b013e31822270ec.
10
Addressing strategy execution challenges to lead sustainable change.应对战略执行挑战,引领可持续变革。
J Nurs Adm. 2011 Jan;41(1):1-4. doi: 10.1097/NNA.0b013e318200288a.